Stay updated on Pembrolizumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page
- Check5 days agoChange DetectedA new revision entry labeled v3.4.3 has been added to the Record History, and the previous v3.4.2 entry has been removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the record history. Removed the funding-lapse notice and Revision: v3.4.1 from the history.SummaryDifference0.8%

- Check41 days agoChange DetectedA government funding lapse notice was added at the top of the page. The revision history now includes Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.8%

- Check48 days agoChange DetectedAdded UI elements for the Record History view: glossary toggle and color-coded (green for additions, red for deletions) highlights, plus a new Revision: v3.4.0 label. The No FEAR Act data line was removed.SummaryDifference1.0%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added and the previous revision v3.3.3 was removed from the Study Record Versions list; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 appears on the page, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. These changes are administrative and do not affect trial data or user actions.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.